Huawei Stroke Study
Research type
Research Study
Full title
Evaluation of Huawei Smartwear for Detection of Atrial Fibrillation in a Post-Stroke Population: The Huawei Stroke Study
IRAS ID
302919
Contact name
Gregory Lip
Contact email
Sponsor organisation
University of Liverpool
Duration of Study in the UK
2 years, 0 months, 0 days
Research summary
What research question is being addressed?
Is a smart band useful to detect atrial fibrillation in patients following a stroke?
How is it of relevance and importance to patients and public?
Atrial fibrillation is a common irregular heart rhythm and increases a person’s risk of stroke. Identifying atrial fibrillation post-stroke means appropriate treatment can be started to reduce the person’s risk of having another stroke.
Who would be eligible?
All adults at participating hospitals who have had an ischaemic stroke (where the stroke is caused by loss of blood flow to the brain) confirmed by a stroke doctor, unless they are unable to provide consent to take part or they are receiving end-of-life care.
What will the participants undergo?
At the time of stroke, patients have a lot of information collected about their health, we will copy information from a patient’s medical records about their health. We will also ask the patients to complete some additional questionnaires including about their health and well-being. We will ask the patients to wear a smart band for four weeks. The smart band will be linked to a mobile phone application. If the person has a phone which works with the band, we will ask them to download the application to their own phone. If the person does not have a compatible phone, the person will be provided with a phone which will be asked to return at the end of the study period. The smart band will track their heart rhythm and if atrial fibrillation is suspected, the person will be invited to attend a hospital appointment. At the hospital appointment, further tests will be conducted, such as an electrocardiogram (ECG), to determine if the person does have atrial fibrillation. We will ask the patients 6 and 12-months later to repeat the questionnaires.
REC name
East Midlands - Nottingham 2 Research Ethics Committee
REC reference
21/EM/0214
Date of REC Opinion
23 Nov 2021
REC opinion
Further Information Favourable Opinion